Literature DB >> 35674933

The role of CCNs in controlling cellular communication in the tumor microenvironment.

Lauren B Birkeness1, Snigdha Banerjee1,2, Mohiuddin Quadir3, Sushanta K Banerjee4,5.   

Abstract

The Cellular communication network (CCN) family of growth regulatory factors comprises six secreted matricellular proteins that promote signal transduction through cell-cell or cell-matrix interaction. The diversity of functionality between each protein is specific to the many aspects of healthy and cancer biology. For example, CCN family proteins modulate cell adhesion, proliferation, migration, invasiveness, apoptosis, and survival. In addition, the expression of each protein regulates many biological and pathobiological processes within its microenvironment to regulate angiogenesis, inflammatory response, chondrogenesis, fibrosis, and mitochondrial integrity. The collective range of CCN operation remains fully comprehended; however, understanding each protein's microenvironment may draw more conclusions about the abundance of interactions and signaling cascades occurring within such issues. This review observes and distinguishes the various roles a CCN protein may execute within distinct tumor microenvironments and the biological associations among them. Finally. We also review how CCN-family proteins can be used in nano-based therapeutic implications.
© 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Entities:  

Keywords:  CCN; Extracellular matrix; Matricellular protein; Neoplastic tissue; Tumor microenvironment

Year:  2022        PMID: 35674933     DOI: 10.1007/s12079-022-00682-2

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.908


  75 in total

1.  CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth.

Authors:  A M Babic; M L Kireeva; T V Kolesnikova; L F Lau
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

2.  In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type.

Authors:  Stefania Benini; Bernard Perbal; Diana Zambelli; Mario Paolo Colombo; Maria Cristina Manara; Massimo Serra; Mariella Parenza; Vincent Martinez; Piero Picci; Katia Scotlandi
Journal:  Oncogene       Date:  2005-06-23       Impact factor: 9.867

3.  CCN5/WISP-2: A micromanager of breast cancer progression.

Authors:  Sushanta K Banerjee; Snigdha Banerjee
Journal:  J Cell Commun Signal       Date:  2012-04-10       Impact factor: 5.782

4.  Pulmonary hypoplasia in the connective tissue growth factor (Ctgf) null mouse.

Authors:  Mark Baguma-Nibasheka; Boris Kablar
Journal:  Dev Dyn       Date:  2008-02       Impact factor: 3.780

5.  CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells.

Authors:  Snigdha Banerjee; Gopal Dhar; Inamul Haque; Suman Kambhampati; Smita Mehta; Krishanu Sengupta; Ossama Tawfik; Teresa A Phillips; Sushanta K Banerjee
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

6.  Human pancreatic cancer progression: an anarchy among CCN-siblings.

Authors:  Sushanta K Banerjee; Gargi Maity; Inamul Haque; Arnab Ghosh; Sandipto Sarkar; Vijayalaxmi Gupta; Donald R Campbell; Daniel Von Hoff; Snigdha Banerjee
Journal:  J Cell Commun Signal       Date:  2016-08-19       Impact factor: 5.782

7.  WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation.

Authors:  Snigdha Banerjee; Neela Saxena; Krishanu Sengupta; Ossama Tawfik; Matthew S Mayo; Sushanta K Banerjee
Journal:  Neoplasia       Date:  2003 Jan-Feb       Impact factor: 5.715

8.  Cyr61/CCN1 targets for chemosensitization in pancreatic cancer.

Authors:  Snigdha Banerjee; Arnab Ghosh; Daniel D VonHoff; Sushanta K Banerjee
Journal:  Oncotarget       Date:  2019-06-04

9.  Aging differentially modulates the Wnt pro-survival signalling pathways in vascular smooth muscle cells.

Authors:  Bethan A Brown; Georgia M Connolly; Carina E J Mill; Helen Williams; Gianni D Angelini; Jason L Johnson; Sarah J George
Journal:  Aging Cell       Date:  2018-12-12       Impact factor: 9.304

Review 10.  Potential Role of CCN Proteins in Breast Cancer: Therapeutic Advances and Perspectives.

Authors:  Kazi Ahsan Ahmed; Tasnin Al Hasib; Shamrat Kumar Paul; Md Saddam; Afsana Mimi; Abu Saim Mohammad Saikat; Hasan Al Faruque; Md Ataur Rahman; Md Jamal Uddin; Bonglee Kim
Journal:  Curr Oncol       Date:  2021-11-26       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.